Skip to content
healthcare.dev

Rimantadine Hydrochloride

NDC 0115-1911, Rimantadine Hydrochloride, tablet, film coated, from Amneal Pharmaceuticals of New York LLC.

Product NDC
0115-1911
Status
Listed
Labeler
Amneal Pharmaceuticals of New York LLC
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA076132
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0115-1911 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RIMANTADINE HYDROCHLORIDE100 mg/1

Pharmacologic classes

Influenza A M2 Protein Inhibitor [EPC]; M2 Protein Inhibitors [MoA]

Package NDCNDC-11Package
0115-1911-0100115191101100 TABLET, FILM COATED in 1 BOTTLE (0115-1911-01)
0115-1911-0200115191102500 TABLET, FILM COATED in 1 BOTTLE (0115-1911-02)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/49f7d69a-820b-4c75-a31d-b2104c019c12

Use it

Look up 0115-1911 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0115-1911 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0115-1911. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.